Vaksina eksperimentale e personalizuar kund\u00ebr kancerit, e zhvilluar nga Moderna dhe Merck, ka dh\u00ebn\u00eb rezultate pozitive n\u00eb prov\u00ebn e par\u00eb t\u00eb Faz\u00ebs 3, duke e afruar terapin\u00eb me nj\u00eb aplikim t\u00eb mundsh\u00ebm p\u00ebr miratim rregullator.<\/p>\n
Vaksina me teknologji mRNA, e kombinuar me imunoterapin\u00eb Keytruda, u testua te m\u00eb shum\u00eb se 1,100 pacient\u00eb me melanom\u00eb me rrezik t\u00eb lart\u00eb ose t\u00eb avancuar, t\u00eb cil\u00ebve tumoret u ishin hequr kirurgjikisht.<\/p>\n
Sipas rezultateve t\u00eb b\u00ebra publike nga kompanit\u00eb, kombinimi i vaksin\u00ebs me Keytruda zgjati ndjesh\u00ebm periudh\u00ebn gjat\u00eb s\u00eb cil\u00ebs pacient\u00ebt mbet\u00ebn pa shenja t\u00eb melanom\u00ebs, krahasuar me trajtimin vet\u00ebm me Keytruda. Terapia gjithashtu uli rrezikun q\u00eb s\u00ebmundja t\u00eb p\u00ebrhapej n\u00eb pjes\u00eb t\u00eb tjera t\u00eb trupit.<\/p>\n
Vaksina \u00ebsht\u00eb e personalizuar p\u00ebr \u00e7do pacient. Ajo projektohet p\u00ebr t\u00eb synuar mutacionet specifike t\u00eb tumorit t\u00eb individit, me synimin q\u00eb sistemi imunitar t\u00eb m\u00ebsoj\u00eb t\u2019i njoh\u00eb dhe t\u2019i sulmoj\u00eb qelizat kancerogjene. Keytruda, nd\u00ebrkoh\u00eb, ndihmon n\u00eb fuqizimin e p\u00ebrgjigjes imunitare.<\/p>\n
Kompanit\u00eb pritet t\u2019i paraqesin rezultatet n\u00eb nj\u00eb konferenc\u00eb t\u00eb ardhshme mjek\u00ebsore.<\/p>\n
Studimi do t\u00eb vijoj\u00eb p\u00ebr t\u00eb vler\u00ebsuar edhe mbijetes\u00ebn e p\u00ebrgjithshme, nd\u00ebrsa ende nuk \u00ebsht\u00eb b\u00ebr\u00eb e ditur se kur do t\u00eb dor\u00ebzohen aplikimet p\u00ebr miratim n\u00eb SHBA.<\/p>\n
Merck i ka cil\u00ebsuar rezultatet si nj\u00eb p\u00ebrmir\u00ebsim klinikisht dometh\u00ebn\u00ebs krahasuar me Keytruda-n vet\u00ebm. Sipas kompanis\u00eb, efektet an\u00ebsore t\u00eb v\u00ebrejtura ishin p\u00ebrgjith\u00ebsisht t\u00eb ngjashme me ato q\u00eb lidhen me vaksinat rutin\u00eb.<\/p>\n
N\u00ebse rezultatet konfirmohen dhe trajtimi merr miratimin rregullator, kombinimi mund t\u00eb p\u00ebrfaq\u00ebsoj\u00eb nj\u00eb hap t\u00eb r\u00ebnd\u00ebsish\u00ebm drejt p\u00ebrdorimit t\u00eb vaksinave t\u00eb personalizuara mRNA n\u00eb trajtimin e kancerit dhe t\u00eb hap\u00eb rrug\u00ebn p\u00ebr prova t\u00eb ngjashme edhe n\u00eb lloje t\u00eb tjera tumoresh.<\/p>","protected":false},"excerpt":{"rendered":"
Vaksina eksperimentale e personalizuar kund\u00ebr kancerit, e zhvilluar nga Moderna dhe Merck, ka dh\u00ebn\u00eb rezultate pozitive n\u00eb prov\u00ebn e par\u00eb t\u00eb Faz\u00ebs 3, duke e afruar terapin\u00eb me nj\u00eb aplikim t\u00eb mundsh\u00ebm p\u00ebr miratim rregullator. Vaksina me teknologji mRNA, e kombinuar me imunoterapin\u00eb Keytruda, u testua te m\u00eb shum\u00eb se 1,100 pacient\u00eb me melanom\u00eb me […]<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-97372","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/zennihost.com\/test\/wp-json\/wp\/v2\/posts\/97372","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/zennihost.com\/test\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zennihost.com\/test\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/zennihost.com\/test\/wp-json\/wp\/v2\/comments?post=97372"}],"version-history":[{"count":0,"href":"https:\/\/zennihost.com\/test\/wp-json\/wp\/v2\/posts\/97372\/revisions"}],"wp:attachment":[{"href":"https:\/\/zennihost.com\/test\/wp-json\/wp\/v2\/media?parent=97372"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zennihost.com\/test\/wp-json\/wp\/v2\/categories?post=97372"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zennihost.com\/test\/wp-json\/wp\/v2\/tags?post=97372"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}